Neutrophil-to-lymphocyte ratios in patients undergoing aortic valve replacement: The PARTNER trials and registries

Authors

Bahira Shahim, Clinical Trials Center Cardiovascular Research Foundation
Alan Zajarias, Washington University School of Medicine in St. Louis
et al

Journal

Journal of the American Heart Association

Publication Date

6-7-2022

Volume

11

Issue

11

First Page

e024091

Document Type

Open Access Publication

DOI

10.1161/JAHA.121.024091

Rights and Permissions

Shahim B, Redfors B, Lindman BR, Chen S, Dahlen T, Nazif T, Kapadia S, Gertz ZM, Crowley AC, Li D, Thourani VH, Kodali SK, Zajarias A, Babaliaros VC, Guyton RA, Elmariah S, Herrmann HC, Cohen DJ, Mack MJ, Smith CR, Leon MB, George I. Neutrophil-to-Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries. J Am Heart Assoc. 2022 Jun 7;11(11):e024091. doi: 10.1161/JAHA.121.024091. Copyright © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. https://doi.org/10.1161/JAHA.121.024091

Recommended Citation

Shahim, Bahira; Zajarias, Alan; and et al, "Neutrophil-to-lymphocyte ratios in patients undergoing aortic valve replacement: The PARTNER trials and registries." Journal of the American Heart Association. 11, 11. e024091 (2022).
https://digitalcommons.wustl.edu/oa_4/41